BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24670266)

  • 1. Effects of eicosapentaenoic acid on the levels of inflammatory markers, cardiac function and long-term prognosis in chronic heart failure patients with dyslipidemia.
    Kohashi K; Nakagomi A; Saiki Y; Morisawa T; Kosugi M; Kusama Y; Atarashi H; Shimizu W
    J Atheroscler Thromb; 2014; 21(7):712-29. PubMed ID: 24670266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of statin therapy on the production of monocyte pro-inflammatory cytokines, cardiac function, and long-term prognosis in chronic heart failure patients with dyslipidemia.
    Nakagomi A; Seino Y; Kohashi K; Kosugi M; Endoh Y; Kusama Y; Atarashi H; Mizuno K
    Circ J; 2012; 76(9):2130-8. PubMed ID: 22785006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of eicosapentaenoic acid on asymmetric dimethylarginine in patients in the chronic phase of cerebral infarction: a preliminary study.
    Hagiwara H; Nishiyama Y; Katayama Y
    J Stroke Cerebrovasc Dis; 2011; 20(5):474-8. PubMed ID: 21277225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure.
    Hsu CP; Lin SJ; Chung MY; Lu TM
    Atherosclerosis; 2012 Dec; 225(2):504-10. PubMed ID: 23092827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations With Eicosapentaenoic Acid to Arachidonic Acid Ratio and Mortality in Hospitalized Heart Failure Patients.
    Watanabe S; Yoshihisa A; Kanno Y; Takiguchi M; Yokokawa T; Sato A; Miura S; Shimizu T; Abe S; Sato T; Suzuki S; Oikawa M; Sakamoto N; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
    J Card Fail; 2016 Dec; 22(12):962-969. PubMed ID: 27138463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential long-term effects of carvedilol on proinflammatory and antiinflammatory cytokines, asymmetric dimethylarginine, and left ventricular function in patients with heart failure.
    Alfieri AB; Briceno L; Fragasso G; Spoladore R; Palloshi A; Bassanelli G; Montano C; Arioli F; Cuko A; Ruotolo G; Margonato A
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):49-54. PubMed ID: 18594474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of eicosapentaenoic acid/arachidonic acid ratio (EPA/AA) in adult patients with congenital heart disease.
    Kanoh M; Inai K; Shinohara T; Tomimatsu H; Nakanishi T
    Heart Vessels; 2017 Dec; 32(12):1513-1522. PubMed ID: 28681101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure.
    Young JM; Strey CH; George PM; Florkowski CM; Sies CW; Frampton CM; Scott RS
    Eur J Heart Fail; 2008 May; 10(5):463-6. PubMed ID: 18430606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure.
    Zairis MN; Patsourakos NG; Tsiaousis GZ; Theodossis Georgilas A; Melidonis A; Makrygiannis SS; Velissaris D; Batika PC; Argyrakis KS; Tzerefos SP; Prekates AA; Foussas SG
    Heart; 2012 Jun; 98(11):860-4. PubMed ID: 22422591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Janikowski K; Lelonek M
    Adv Clin Exp Med; 2017 Sep; 26(6):931-938. PubMed ID: 29068593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Administration of Eicosapentaenoic Acid Improves Post-Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization.
    Takamura M; Kurokawa K; Ootsuji H; Inoue O; Okada H; Nomura A; Kaneko S; Usui S
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28223437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of eicosapentaenoic acid treatment on the fibrous cap thickness in patients with coronary atherosclerotic plaque: an optical coherence tomography study.
    Yamano T; Kubo T; Shiono Y; Shimamura K; Orii M; Tanimoto T; Matsuo Y; Ino Y; Kitabata H; Yamaguchi T; Hirata K; Tanaka A; Imanishi T; Akasaka T
    J Atheroscler Thromb; 2015; 22(1):52-61. PubMed ID: 25132379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia.
    Satoh-Asahara N; Shimatsu A; Sasaki Y; Nakaoka H; Himeno A; Tochiya M; Kono S; Takaya T; Ono K; Wada H; Suganami T; Hasegawa K; Ogawa Y
    Diabetes Care; 2012 Dec; 35(12):2631-9. PubMed ID: 22912426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.
    Tripepi G; Mattace Raso F; Sijbrands E; Seck MS; Maas R; Boger R; Witteman J; Rapisarda F; Malatino L; Mallamaci F; Zoccali C
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1714-21. PubMed ID: 21642364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of walking on heart rate recovery, endothelium modulators and quality of life in patients with heart failure.
    Tsarouhas K; Karatzaferi C; Tsitsimpikou C; Haliassos A; Kouretas D; Pavlidis P; Veskoukis A; Adamopoulos S; Kyriakides Z; Constantinou L; Koutedakis Y; Rentoukas E
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):594-600. PubMed ID: 21450607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional Status is Associated with Inflammation and Predicts a Poor Outcome in Patients with Chronic Heart Failure.
    Nakagomi A; Kohashi K; Morisawa T; Kosugi M; Endoh I; Kusama Y; Atarashi H; Shimizu W
    J Atheroscler Thromb; 2016 Jun; 23(6):713-27. PubMed ID: 26782970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study.
    Takahashi M; Ando J; Shimada K; Nishizaki Y; Tani S; Ogawa T; Yamamoto M; Nagao K; Hirayama A; Yoshimura M; Daida H; Nagai R; Komuro I
    BMC Cardiovasc Disord; 2017 Jan; 17(1):41. PubMed ID: 28125968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure.
    Chen Y; Ji XW; Zhang AY; Lv JC; Zhang JG; Zhao CH
    Arch Med Res; 2014 Apr; 45(3):263-9. PubMed ID: 24508287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.